Bristol-Myers Squibb Co (BMY)
44.85
+0.15
(+0.34%)
USD |
NYSE |
Apr 26, 16:00
44.87
+0.02
(+0.04%)
Pre-Market: 20:00
Bristol-Myers Squibb Cash from Operations (Quarterly): 2.834B for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 2.834B |
December 31, 2023 | 4.252B |
September 30, 2023 | 4.751B |
June 30, 2023 | 1.887B |
March 31, 2023 | 2.97B |
December 31, 2022 | 3.306B |
September 30, 2022 | 3.687B |
June 30, 2022 | 2.261B |
March 31, 2022 | 3.812B |
December 31, 2021 | 4.057B |
September 30, 2021 | 5.266B |
June 30, 2021 | 3.06B |
March 31, 2021 | 3.824B |
December 31, 2020 | 3.355B |
September 30, 2020 | 2.267B |
June 30, 2020 | 4.493B |
March 31, 2020 | 3.937B |
December 31, 2019 | 2.181B |
September 30, 2019 | 2.556B |
June 30, 2019 | 2.083B |
March 31, 2019 | 1.39B |
December 31, 2018 | 3.555B |
September 30, 2018 | 1.279B |
June 30, 2018 | 1.057B |
March 31, 2018 | 1.175B |
Date | Value |
---|---|
December 31, 2017 | 1.117B |
September 30, 2017 | 1.713B |
June 30, 2017 | 1.584B |
March 31, 2017 | 861.00M |
December 31, 2016 | 1.443B |
September 30, 2016 | 1.404B |
June 30, 2016 | 439.00M |
March 31, 2016 | -228.00M |
December 31, 2015 | 884.00M |
September 30, 2015 | 524.00M |
June 30, 2015 | 71.00M |
March 31, 2015 | 626.00M |
December 31, 2014 | 572.00M |
September 30, 2014 | 903.00M |
June 30, 2014 | 1.056B |
March 31, 2014 | 617.00M |
December 31, 2013 | 1.41B |
September 30, 2013 | 1.053B |
June 30, 2013 | 1.51B |
March 31, 2013 | -428.00M |
December 31, 2012 | 836.00M |
September 30, 2012 | 4.584B |
June 30, 2012 | 1.134B |
March 31, 2012 | 387.00M |
December 31, 2011 | 1.568B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
1.887B
Minimum
Jun 2023
5.266B
Maximum
Sep 2021
3.342B
Average
3.330B
Median
Cash from Operations (Quarterly) Benchmarks
Amgen Inc | 538.00M |
Biogen Inc | 553.20M |
Gilead Sciences Inc | 2.169B |
Karuna Therapeutics Inc (DELISTED) | -111.06M |
2seventy bio Inc | -63.60M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -19.62B |
Cash from Financing (Quarterly) | 14.64B |
Free Cash Flow | 12.51B |
Free Cash Flow Per Share (Quarterly) | 1.260 |
Free Cash Flow to Equity (Quarterly) | -13.36B |
Free Cash Flow to Firm (Quarterly) | 2.989B |
Free Cash Flow Yield | 13.57% |